The Use of Intravenous Iron in Pregnancy

 TARGET GROUP: WOMEN

OBJECTIVES

·        To prescribe intravenous iron for IDAP, while half prescribe it for ID without anaemia.

·        To adherence to national guidelines regarding use of intravenous iron appeared suboptimal.

·        To provide the optimal treatment of IDAP and ID without anaemia in antenatal and postnatal settings, particularly establishing important clinical outcomes.

SUMMARY

Iron deficiency anaemia in pregnancy (IDAP) affects 11–18% of Australian pregnancies and is associated with adverse perinatal outcomes. National prescribing data suggests the use of intravenous iron in pregnancy is increasingly common. This study aimed to: 1) Establish the current patterns of intravenous iron use by Fellows of the Royal Australian and New Zealand College of Obstetricians (FRANZCOG) when treating iron deficiency and IDAP including immediately postpartum and; 2) Assess FRANZCOG opinions regarding potential trial of intravenous iron for first-line treatment of IDAP.

REFERENCE

https://digital.library.adelaide.edu.au/dspace/bitstream/2440/132003/2/hdl_132003.pdf